Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Pediatrics/Neonatology
 Disease Category: Growth Hormone Deficiencies/Abnormalities
Location: United States, CA

Trial Information

SWOG S1013: A Prospective Study of Epidermal Growth Factor Receptor (HER-1/EGFR) Inhibitor -Induced Dermatalogic Toxicity: Validation of the Functional Assessment of Cancer Therapy-EGFRI 18 (FACT-EGFR 18)Questionnaire for EGFRI-Induced Skin Toxicities

The purpose of this study is to have patients on EGFR inhibitors who experience skin side effects, provide information about their skin symptoms through the FACT-EGFR 18 questionnaire, to see if it can be used as a reliable tool.

Patient Inclusion/Exclusion Criteria:


- See http://clinicaltrials.coh.org for additional information.


City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Map

Research Center Information: City of Hope

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.